TYCOLET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tycolet, and when can generic versions of Tycolet launch?
Tycolet is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in TYCOLET is acetaminophen; hydrocodone bitartrate. There is one drug master file entry for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TYCOLET?
- What are the global sales for TYCOLET?
- What is Average Wholesale Price for TYCOLET?
Summary for TYCOLET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | TYCOLET at DailyMed |
US Patents and Regulatory Information for TYCOLET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | TYCOLET | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 089385-001 | Aug 27, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
